elisabetta setola
@setolae
Followers
66
Following
230
Statuses
212
Sarcoma Oncologist at IEO- European Institute of Oncology,
Milan, Lombardy
Joined January 2013
RT @oncodaily: Breaking Barriers in Advanced Sarcoma Treatment @breelynwilkyMD @JTrentMDPhD
#Cancer #OncoDaily…
0
7
0
RT @breelynwilkyMD: Very excited to see this in print! Such promising outcomes for immune cold #sarcomas with Botensilimab Plus Balstilimab…
0
20
0
RT @VivekSubbiah: Results of a phase Ib study of olaparib with concomitant radiotherapy in soft-tissue sarcoma: a French sarcoma group stud…
0
5
0
RT @SuzieSiegel: Dr. Pedro Antonio Hermida de Viveiros will discuss the phase 2 trial of zanzalintinib for leiomyosarcoma patients at @Nort…
0
2
0
RT @sarcomapatients: Don't miss out on our first annual conference in the USA! Registration for the SPAGN Annual conference is still open b…
0
3
0
RT @EHEfoundation: 🎥 EHE 360 Connect: "Sirolimus for the Treatment of EHE" with Dr. Silvia Stacchiotti is available:
0
1
0
RT @saxotomy: Congrats! A big step in #immunotherapy for #sarcoma especially for visceral #angiosarcoma which typically unlikely to respond…
0
2
0
RT @ItaSarcomaGroup: 📣Giovedì 30 gennaio alle ore 13.30 su #Rai2 , nella rubrica del Tg2🟥"Tutto il bello che c'è" andrà in onda un servizio…
0
6
0
RT @schoffski: According to a press release GSK will acquire IDRx! The acquisition includes IDRX-42 as lead molecule of the Boston-based bi…
0
5
0
RT @CFLabsResearch: For those undaunted by drugging the currently undruggable: we're excited to announce the TBXT Challenge, a drug discove…
0
10
0
RT @alegronchi: Hey, watch out... here is a nice recap of the best published studies in 2023/2024 in #sarcoma Thanks to all the investigato…
0
40
0
RT @AdamJSchoenfeld: Thrilled to share our article this Thanksgiving Eve! 🍂 With expansion of HLA-restricted therapies, we show HLA genotyp…
0
8
0
RT @IstTumori: 🎉 Siamo orgogliosi di annunciare che la Dr.ssa Silvia Stacchiotti ha ricevuto un prestigioso riconoscimento agli Italian Kno…
0
13
0
RT @EORTC: ✨EORTC’s #STRASS2 #ClinicalTrial exploring whether chemotherapy before surgery can improve outcomes and survival for #sarcoma pa…
0
4
0
RT @MorphologyAmigo: Haembyte Converting b/w Different Anticoagulants Useful Chat👇👇 #medicine #hematology #meded #medtwitter #blooducation…
0
34
0
RT @euroewing: Only 6 days left to apply! Early career researchers in #ewing #sarcoma - apply here to present a flash talk at the virtual (…
0
3
0
RT @VivekSubbiah: ⭐️Nice review @CD_AACR 👉🏼The Journey of Antibody-Drug Conjugates: Lessons Learned from 40 Years of Development. https://…
0
16
0
RT @HuangLabICR: Wonderful talks from @priyachudasama5 & @DCalleMD sharing with us the latest in telomere maintenance and sarculator respec…
0
3
0
RT @ManuPalmerini: #Bonetumors: With #nivolumab and #sunitinib 6 months PFSR 42% and responses observed in 1/4 patients with #dediffere…
0
5
0